冷凍卵子及胚胎庫市場機會、成長要素、產業趨勢分析及2026年至2035年預測

全球卵子冷凍和胚胎庫市場預計到 2025 年價值 51 億美元，預計到 2035 年將達到 136 億美元，年複合成長率為 10.3%。

在全球範圍內，個人和夫婦對生育治療的認知和社會接受度不斷提高，推動了市場成長。冷凍保存技術的進步顯著改善了保存效果，增強了人們對長期生育計畫的信心。同時，全球不孕症持續上升，對輔助生殖解決方案的需求也持續成長。生育診所的擴張、醫療網路間合作的加強以及更多資助項目的推出，進一步加速了市場普及。卵子冷凍和胚胎庫使個人能夠保存生育能力，並在生育計劃方面擁有更大的靈活性。由於生活方式的改變、醫療方面的考慮以及職業責任等因素影響生育決策，越來越多的人選擇這些解決方案。隨著生殖醫學更加以患者為中心，技術也日益先進，生育力保存服務正從小眾服務轉變為主流醫療保健選擇，預計將在已開發經濟體和新興經濟體實現長期市場成長。

預計到2025年，胚胎庫市場規模將達到30億美元，2026年至2035年的複合年成長率將達到10.2%。該市場透過保存具有活性的胚胎以供未來使用，為長期生育計畫提供支持，與未受精卵儲存相比，可提供更高的操作確定性。希望推遲生育的人群以及接受影響生育能力的醫療手術的人群對胚胎庫的需求持續成長。

預計到 2025 年，短期儲存領域將佔市場佔有率的 67%，到 2035 年將以 10.2% 的複合年成長率成長。短期儲存解決方案廣泛應用於積極的生育治療週期以及影響生殖健康的暫時性醫療狀況，這使得該領域成為一個穩定的收入來源。

亞太地區卵子冷凍和胚胎庫市場預計到2025年將達到17億美元，呈現強勁的市場成長動能。人們意識的提高、計劃生育時間的改變以及輔助生殖技術的普及，都推動了全部區域需求的成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章業界考察

• 生態系分析
• 產業影響因素
  • 促進要素
    • 提高女性和夫婦對生育力保存選擇的認知和接受度
    • 冷凍保存技術的進步
    • 全球不孕不育率上升
    • 生育診所和伴侶數量增加
  • 產業潛在風險與挑戰
    • 卵子冷凍和胚胎儲存高成本
    • 關於冷凍卵子和胚胎的使用和處置的倫理和法律問題
  • 市場機遇
    • 拓展新興市場
    • 擴大保險範圍
• 成長潛力分析
• 監管環境
• 技術進步
  • 當前技術趨勢
  • 新興技術
• 救贖方案
• 2024年定價分析
• 未來市場趨勢
• 波特五力分析
• PESTEL 分析

第4章 競爭情勢

• 介紹
• 公司市佔率分析
• 企業矩陣分析
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 重大進展
  • 併購
  • 合作夥伴關係和合資企業
  • 新產品發布
  • 擴張計劃

第5章 依服務類型分類的市場估算與預測，2022-2035年

• 冷凍卵子
• 胚胎庫

6. 按儲存期分類的市場估算與預測，2022-2035 年

• 短期儲存
• 長期儲存

第7章 按技術分類的市場估計與預測，2022-2035年

• 玻璃化
• 慢速冷凍

第8章 按應用領域分類的市場估算與預測，2022-2035年

• 生育力保存治療
• 捐卵子/捐胚胎計劃
• 基因篩檢
• 腫瘤生育力

第9章 按年齡層別分類的市場估計與預測，2022-2035年

• 30歲以下
• 31至40歲
• 41歲或以上

第10章 2022-2035年各地區市場估計與預測

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國

第11章 公司簡介

• Boston IVF
• Carrot
• CCRM Fertility
• Cryos International
• Extend Fertility
• Genea Pty
• IVIRMA
• Monash IVF Group
• New Hope IVF &Fertility Clinic
• Ovation Fertility
• Progyny
• ReproTech
• RMA Network
• Shady Grove Fertility
• Spring Fertility
• WINFertility

The Global Egg Freezing and Embryo Banking Market was valued at USD 5.1 billion in 2025 and is estimated to grow at a CAGR of 10.3% to reach USD 13.6 billion by 2035.

Market growth is supported by rising awareness and broader social acceptance of fertility preservation among individuals and couples worldwide. Advancements in cryopreservation technologies have significantly improved storage outcomes, increasing confidence in long-term reproductive planning. At the same time, infertility rates continue to rise globally, creating sustained demand for assisted reproductive solutions. Expansion of fertility clinics, stronger collaboration across healthcare networks, and growing availability of supportive financial programs are further accelerating market adoption. Egg freezing and embryo banking allow individuals to preserve reproductive potential and plan parenthood timelines more flexibly. These solutions are increasingly chosen due to lifestyle changes, medical considerations, and professional commitments that influence reproductive decisions. As reproductive healthcare becomes more patient-centric and technologically advanced, fertility preservation services are transitioning from niche offerings to mainstream medical options, positioning the market for long-term growth across both developed and emerging economies.

The embryo banking segment generated USD 3 billion in 2025 and is expected to grow at a CAGR of 10.2% during 2026-2035. This segment supports long-term reproductive planning by enabling preserved embryos to remain viable for future use, offering higher procedural certainty compared to unfertilized preservation methods. Demand continues to increase among individuals seeking delayed parenthood or undergoing fertility-impacting medical treatments.

The short-term storage segment accounted for 67% share in 2025 and is forecast to grow at a CAGR of 10.2% through 2035. Short-duration storage solutions are widely used during active fertility treatment cycles or temporary medical conditions that affect reproductive health, making this segment a consistent revenue contributor.

Asia Pacific Egg Freezing and Embryo Banking Market was valued at USD 1.7 billion in 2025 and is experiencing strong market momentum. Growing awareness, shifting family planning timelines, and improving access to assisted reproductive healthcare are contributing to rising demand across the region.

Key companies operating in the Global Egg Freezing and Embryo Banking Market include IVIRMA, Progyny, Monash IVF Group, Shady Grove Fertility, Cryos International, Boston IVF, ReproTech, Genea Pty Limited, RMA Network, Extend Fertility, WINFertility, Ovation Fertility, CCRM Fertility, Spring Fertility, New Hope IVF & Fertility Clinic, and Carrot. Companies in the egg freezing and embryo banking market are strengthening their market position through service expansion, technology investment, and strategic collaborations. Many providers are enhancing cryopreservation protocols to improve storage reliability and clinical outcomes. Expansion of clinic networks and partnerships with healthcare systems is helping improve geographic reach and patient access. Firms are also focusing on transparent pricing models, patient education platforms, and digital engagement tools to improve awareness and trust. Investment in data management and laboratory automation is supporting operational efficiency.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Service type trends
  • 2.2.3 Storage duration trends
  • 2.2.4 Technology trends
  • 2.2.5 Application trends
  • 2.2.6 Age group trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing awareness and acceptance of fertility preservation options among women and couples
    • 3.2.1.2 Advancements in cryopreservation techniques
    • 3.2.1.3 Rising global infertility rates
    • 3.2.1.4 Increasing number of fertility clinics and partnerships
  • 3.2.2 Industry Pitfalls and Challenges
    • 3.2.2.1 High cost of egg freezing and embryo banking
    • 3.2.2.2 Ethical and legal issues surrounding the use and disposition of frozen eggs and embryos
  • 3.2.3 Market Opportunities
    • 3.2.3.1 Expansion into emerging markets
    • 3.2.3.2 Insurance coverage expansion
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological advancements
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Reimbursement scenario
• 3.7 Pricing analysis, 2024
• 3.8 Future market trends
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Service Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Egg freezing
• 5.3 Embryo banking

Chapter 6 Market Estimates and Forecast, By Storage duration, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Short-term storage
• 6.3 Long-term storage

Chapter 7 Market Estimates and Forecast, By Technology, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Vitrification
• 7.3 Slow freezing

Chapter 8 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Fertility preservation
• 8.3 Donor egg/embryo programs
• 8.4 Genetic screening
• 8.5 Oncofertility

Chapter 9 Market Estimates and Forecast, By Age Group, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 Under 30
• 9.3 31 to 40
• 9.4 Over 41

Chapter 10 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 India
  • 10.4.3 Japan
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 South Africa
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Boston IVF
• 11.2 Carrot
• 11.3 CCRM Fertility
• 11.4 Cryos International
• 11.5 Extend Fertility
• 11.6 Genea Pty
• 11.7 IVIRMA
• 11.8 Monash IVF Group
• 11.9 New Hope IVF & Fertility Clinic
• 11.10 Ovation Fertility
• 11.11 Progyny
• 11.12 ReproTech
• 11.13 RMA Network
• 11.14 Shady Grove Fertility
• 11.15 Spring Fertility
• 11.16 WINFertility